Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

hepatocellular carcinoma

  • You have access
    The In Vivo Radiosensitizing Effect of Magnolol on Tumor Growth of Hepatocellular Carcinoma
    YU-SHAN CHEN, ROU SUN, WEI-LUNG CHEN, YU-CHEN YAU, FEI-TING HSU, JING-GUNG CHUNG, CHIA-JUNG TSAI, CHIA-LING HSIEH, YING-MING CHIU and JIANN-HWA CHEN
    In Vivo July 2020, 34 (4) 1789-1796; DOI: https://doi.org/10.21873/invivo.11973
  • You have access
    Prognostic Significance of Treatment Strategies for the Recurrent Hepatocellular Carcinomas After Radical Resection
    RYO SAITO, HIDETAKE AMEMIYA, NAOHIRO HOSOMURA, HIROMICHI KAWAIDA, SUGURU MARUYAMA, HIROKI SHIMIZU, SHINJI FURUYA, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAIDUKE ICHIKAWA
    In Vivo May 2020, 34 (3) 1265-1270; DOI: https://doi.org/10.21873/invivo.11900
  • You have access
    Expression and Prognostic Significance of CDK8 and β-Catenin in Hepatocellular Carcinoma
    SONG IY HAN and SUNG-CHUL LIM
    In Vivo May 2020, 34 (3) 1387-1394; DOI: https://doi.org/10.21873/invivo.11918
  • You have access
    Astragaloside IV Induces Apoptosis, G1-Phase Arrest and Inhibits Anti-apoptotic Signaling in Hepatocellular Carcinoma
    CHUN-MIN SU, HSIAO-CHIA WANG, FEI-TING HSU, CHUN-HUI LU, CHIEN-KAI LAI, JING-GUNG CHUNG and YU-CHENG KUO
    In Vivo March 2020, 34 (2) 631-638; DOI: https://doi.org/10.21873/invivo.11817
  • You have access
    A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes
    EUNAE CHO, HYUN A. CHO, CHUNG HWAN JUN, HEE JOON KIM, SUNG BUM CHO and SUNG KYU CHOI
    In Vivo September 2019, 33 (5) 1411-1420; DOI: https://doi.org/10.21873/invivo.11618
  • You have access
    Characteristics and Outcomes of Extreme Elderly Patients With Hepatocellular Carcinoma in South Korea
    JI HO SEO, DONG HYUN KIM, EUNAE CHO, CHUNG HWAN JUN, SEON YOUNG PARK, SUNG BUM CHO, CHANG HWAN PARK, HYUN SOO KIM, SUNG KYU CHOI and JONG SUN REW
    In Vivo January 2019, 33 (1) 145-154; DOI: https://doi.org/10.21873/invivo.11451
  • You have access
    Severe Vitamin D Deficiency Increases Mortality Among Patients With Liver Cirrhosis Regardless of the Presence of HCC
    ANTONIO RICCARDO BUONOMO, RICCARDO SCOTTO, EMANUELA ZAPPULO, MARIAGIOVANNA NERILLI, BIAGIO PINCHERA, GIUSEPPE PERRUOLO, PIETRO FORMISANO, SALVATORE NAPPA and IVAN GENTILE
    In Vivo January 2019, 33 (1) 177-182; DOI: https://doi.org/10.21873/invivo.11456
  • You have access
    Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells
    LIN-YEN KUAN, WEI-LUNG CHEN, JIANN-HWA CHEN, FEI-TING HSU, TSU-TE LIU, WEI-TING CHEN, KAI-LEE WANG, WEN-CHANG CHEN, YU-CHANG LIU and WEI-SHU WANG
    In Vivo November 2018, 32 (6) 1361-1368; DOI: https://doi.org/10.21873/invivo.11387
  • You have access
    PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma – A Pilot Study
    SARKA SVOBODOVA, MARIE KARLIKOVA, ONDREJ TOPOLCAN, LADISLAV PECEN, MARTINA PESTOVA, OTTO KOTT, VLADISLAV TRESKA, DAVID SLOUKA and RADEK KUCERA
    In Vivo November 2018, 32 (6) 1551-1554; DOI: https://doi.org/10.21873/invivo.11413
  • You have access
    Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation
    KUN-CHING LEE, WEI-TING CHEN, YU-CHANG LIU, SONG-SHEI LIN and FEI-TING HSU
    In Vivo September 2018, 32 (5) 1097-1103; DOI: https://doi.org/10.21873/invivo.11351

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
In Vivo

© 2026 In Vivo

Powered by HighWire